Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-12 06:10 am Purchase | 2021-11-02 | 13G | Compass Therapeutics, Inc. CMPX | Foresite Capital Fund V L.P. | 5,500,000 5.600% | 5,500,000 (New Position) | Filing History |
| 2021-11-09 5:30 pm Purchase | 2021-11-04 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,071,547 18.400% | 5,357,143 (+42.13%) | Filing History |
| 2021-07-14 5:08 pm Purchase | 2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 12,714,404 20.400% | 12,714,404 (New Position) | Filing History |
| 2021-02-08 10:19 am Purchase | 2021-02-05 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 4,122,414 6.744% | 4,122,414 (New Position) | Filing History |
| 2020-08-10 09:23 am Purchase | 2020-06-19 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 2,781,497 5.333% | 21,417 (+0.78%) | Filing |
| 2020-06-30 1:39 pm Purchase | 2020-06-29 | 13G | Compass Therapeutics, Inc. CMPX | ANDERSON ERRIK | 3,244,729 10.100% | 3,244,729 (New Position) | Filing |
| 2020-06-29 6:27 pm Purchase | 2020-06-17 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 12,714,404 24.400% | 12,714,404 (New Position) | Filing |
| 2020-06-29 11:45 am Purchase | 2020-06-26 | 13G | Compass Therapeutics, Inc. CMPX | FMR LLC | 2,760,080 5.292% | 2,760,080 (New Position) | Filing |
| 2020-06-26 3:56 pm Purchase | 2020-06-17 | 13D | Compass Therapeutics, Inc. CMPX | Ferneau Philip | 2,579,342 4.900% | 2,579,342 (New Position) | Filing |
| 2020-06-26 2:53 pm Purchase | 2020-06-17 | 13D | Compass Therapeutics, Inc. CMPX | Schuetz Thomas J. | 4,525,467 8.700% | 4,525,467 (New Position) | Filing |